Related Experiment Videos
[Calcium channel blocker]
1Department of Medicine (Hypertension and Cardiorenal Disease), Dokkyo University School of Medicine.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|October 31, 1998
Summary
Long-acting calcium antagonists (CA) are widely used for coronary heart disease (CHD) and hypertension. However, their long-term effects and benefits in CHD patients require further investigation through clinical trials.
Area of Science:
- Cardiology
- Pharmacology
Context:
- Coronary heart disease (CHD) management requires balancing oxygen supply and demand.
- Calcium antagonists (CA) are popular for treating CHD and hypertension due to vasodilating and hypotensive effects.
- Short-acting CA pose risks (steal phenomenon, hypotension, sympathetic activation) in CHD.
Purpose:
- To review the current understanding of calcium antagonists in CHD treatment.
- To highlight the shift towards long-acting CA in clinical practice.
- To identify the need for further research on long-term effects of long-acting CA in CHD.
Summary:
- Long-acting calcium antagonists (CA) are preferred over short-acting agents for treating coronary heart disease (CHD) and hypertension.
- While CA offer benefits in oxygen supply augmentation and demand reduction, long-term treatment effects in CHD patients remain unclear.
- Current evidence necessitates further clinical trials to ascertain the long-term efficacy and safety of long-acting CA, including in primary prevention.
Impact:
- Informs clinical practice regarding the selection of CA for CHD and hypertension.
- Identifies knowledge gaps in the long-term management of CHD with CA.
- Guides future research directions for evaluating long-acting CA in cardiovascular disease prevention and treatment.